top of page

News

Search
abilbaoerezkano
Mar 26, 2024
1 min read

Sarel Fleishman is a professor and head of the Protein Design Lab (https://lnkd.in/d2Su-kEK) at the Weizmann Institute of Science in Israel. The lab specializes in developing one-shot methods for designing #enzymes and #biologics. Some of the methods developed by the lab, such as PROSS and FuncLib, have become state-of-the-art in computational optimization of protein stability, expression levels, and activity. These and other tools are accessible to all scientists through web servers (https://lnkd.in/dsbe2zHY) and have resulted in more than 100 peer-reviewed papers and patent filings. These methods have served as the basis for founding two #biotechnology startups: Scala Biodesign specializes in optimizing biologics and enzymes, and Plantae Bioscience optimizes the health and nutritional value of crops.


The W-BioCat project will put the reliability of the lab’s design methods to a stringent test. Instead of designing just one enzyme at a time, this project calls for co-optimization of an entire enzymatic pathway. The lab will combine new methods in #AI-based structure prediction of enzymes with its proven methods for improving heterologous expression levels and specific activity. It will collaborate with other teams in the consortium to select the most promising enzyme targets for design, test the predictions, and improve the designs.


The ability to design optimal enzymatic pathways will be a landmark for promoting #sustainable #biocatalytic solutions to complex chemical synthesis challenges. We are eager to contribute to this effort!



abilbaoerezkano
Mar 26, 2024
1 min read

Last week we kicked off the W-BioCat project with a dynamic hybrid meeting (online and in person in Delft, The Netherlands) 🚀


18 experts from Delft University of Technology, Weizmann Institute of Science, Università degli Studi di Firenze, University of Oxford, EvoEnzyme, HydRegen, together with the Industrial Advisory Board formed by Evonik, Axxence, and ChainCraft will focus on the development of tungsten-containing enzymes for application in a sustainable chemical industry. The project is supported by the European Innovation Council and SMEs Executive Agency (EISMEA).


During the meeting, we delved into crucial aspects for the W-BioCat project and set the foundation for a successful journey ahead:

📋 Project Plan: Setting the roadmap to navigate through the project objectives and outcomes.

🔍 Data Management Plan: Ensuring the effective handling, storage, and sharing of our project data.

📡 Communication and Dissemination Plan: Strategizing how we'll share our progress, findings, and new methods with the wider community.

💡 IP Strategy and Exploitation Plan: Safeguarding the intellectual property while maximizing its potential for impact.


In addition, two Public Lectures were attended by more than 45 people. Maurice Oltheten from ChainCraft gave a lecture on “Turning chemistry circular” and Kylie Vincent from University of Oxford on “Exploiting hydrogenase in biotechnology enables hydrogen as a cleaner reductant”.


Finally, we went on a Lab Tour to explore Delft University of Technology facilities and resources.


Looking forward to the exciting journey ahead!



abilbaoerezkano
Mar 20, 2024
1 min read

EvoEnzyme SL https://evoenzyme.com  is a spin-off company from the Institute of Catalysis (ICP, CSIC) in Madrid. The company develops and commercializes customized biocatalysts (obtained by protein engineering) for industrial applications. EvoEnzyme also has wide expertise in the design and execution of customized Directed Evolution R&D projects. The company was created after more than 20 years of research from the laboratory of Prof. Miguel Alcalde (CSIC), a leading laboratory on the evolution of fungal oxidoreductases https://miguelalcaldelab.eu. It is founded on the most relevant basis of knowledge, protocols, methods and overall research experience. EvoEnzyme has a strong drive in the development of top-notch technologies for Directed Evolution, supported by the machinery of Saccharomyces cerevisiae, with an array of library creation methods and high-throughput screening assays. Based on engineering efforts, the company has a wide panel of evolved fungal -unspecific- peroxygenases (UPOs), high-redox potential laccases, versatile peroxidases, aryl-alcohol oxidases and hydrolases ready for industrial applications. Additionally, the laboratory of EvoEnzyme works on the development of bioprocesses for enzyme production in yeast (S. cerevisiae and Pichia pastoris) from bench to pilot plant bioreactors.


EvoEnzyme is located at the Scientific Park in Cantoblanco Campus (Madrid). Cantoblanco is declared a Campus of International Excellence, where The Autonomous University of Madrid (UAM) has seven Faculties, a Higher Polytechnic School (EPS) and it is also home for than 30 research centres and institutes with intense presence of the Spanish National Research Council (CSIC).


As a proud contributor to the W-BioCat project, EvoEnzyme puts effort into protein engineering, employing ancestral reconstruction, resurrection, and directed evolution for W-enzymes. The company’s expertise plays a pivotal role in shaping novel W-enzyme systems, driving successful development and optimization.




Coordinator

Peter-Leon Hagedoorn

Department of Biotechnology
Delft University of Technology

W-BioCat logo

Van der Maasweg 9

2629HZ Delft, The Netherlands

+31 15 2782334

  • Linkedin

Thanks for submitting!

©2023 by Peter-Leon Hagedoorn

bottom of page